Clinical trial Recruiting at 1 site Interventional Ages 20 to 40

Comparing photobiostimulation and pulsed electromagnetic field treatments for chronic rhinosinusitis

Official title: Effect of Photobiostimulation Versus Pulsed Electromagnetic Field on Quality of Life in Adults With Chronic Rhinosinusitis

Run by Cairo University · NCT06986629 · Data updated 2026-11-12

This study tests whether two new treatments, light therapy and electromagnetic field therapy, can help adults with chronic sinus issues feel better compared to standard treatments.

More Low Level Laser Therapy trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedJuly 1, 2025
Study endsAugust 1, 2025
Registry record updatedMay 23, 2025
Trial IDNCT06986629 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 to 40 with mild to moderate chronic rhinosinusitis symptoms and a positive allergy test.

Probably not a fit

Patients with severe systemic diseases, recent surgeries, or those on long-term corticosteroids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of photobiostimulation and pulsed electromagnetic field therapy on adults suffering from chronic rhinosinusitis. It aims to evaluate improvements in quality of life, pulmonary function, headache frequency, total nasal symptoms, and mean platelet volume. Participants will undergo these non-invasive treatments to assess their effectiveness compared to traditional therapies. The study targets individuals aged 20 to 40 with mild to moderate symptoms and confirmed allergies to common perennial allergens.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive treatment option that significantly improves the quality of life for patients with chronic rhinosinusitis.

How similar studies have gone: Other studies have shown promise with similar non-invasive therapies, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants suffering from mild to moderate symptoms (baseline Total nasal symptoms score ≤ 9).
2. Subjects age range from 20 to 40 years old.
3. Patients of both sexes.
4. proven positive allergy test (skin prick test or multiple allergen simultaneous test) to any of the common perennial allergens such as dust mites, molds, insects, and animal dander within the last 12 months

Exclusion Criteria:

* Pregnant or breastfeeding women.
* Patients with a definite deviated nasal septum, or history of operation within the last 6 months.
* Hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, active respiratory disease like asthma, or other systemic diseases.
* Long-term use of corticosteroids or immunosuppressive agents.
* Participation in another clinical study within 30 days.
* Hyperthyroidism
* Patients who had used antihistamines within 1 week, topical corticosteroids within 2 weeks, systemic corticosteroids within 4 weeks, anticholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, nonsteroidal analgesics within 2 weeks, and other drugs that the researchers believed were inappropriate.
* Patients with Tattoos, moles and dark skin

Where it's running

  • out-patient clinic, faculty of physical therapy, October University for Modern Sciences and Arts
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.